Haemonetics Additive Solution Formula 3 (AS-3) is a Extracorporeal Solution in the Human Prescription Drug category. It is labeled and distributed by Haemonetics Corporation. The primary component is Citric Acid Monohydrate; Sodium Phosphate, Monobasic, Monohydrate; Sodium Chloride; Adenine; Anhydrous Dextrose; Trisodium Citrate Dihydrate.
| Product ID | 57826-462_6ad88922-a8dc-6674-e053-2991aa0a6697 |
| NDC | 57826-462 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Haemonetics Additive Solution Formula 3 (AS-3) |
| Generic Name | Citric Acid Monohydrate, Sodium Phosphate, Monobasic, Monohydrate, Sodium Chloride, Adenine, Anhydrous Dextrose, Trisodium Citrate Dihydrate |
| Dosage Form | Solution |
| Route of Administration | EXTRACORPOREAL |
| Marketing Start Date | 2013-01-07 |
| Marketing Category | NDA / NDA |
| Application Number | BN000127 |
| Labeler Name | Haemonetics Corporation |
| Substance Name | CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM CHLORIDE; ADENINE; ANHYDROUS DEXTROSE; TRISODIUM CITRATE DIHYDRATE |
| Active Ingredient Strength | 4 mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL |
| Pharm Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |